Customize your JAMA Network experience by selecting one or more topics from the list below.
The Original Investigation titled “Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: a Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials,”1 published online August 19, 2019, had errors in the Results and Table 1. The number of patients who had a new stroke (ischemic or hemorrhagic) receiving aspirin alone at 90 days should be 459. In addition, the 95% CI for the adjusted hazard ratio for the association of clopidogrel-aspirin and total hemorrhage (major or minor hemorrhage) should be 1.39 to 2.54. This article was corrected online.
Errors in Results and Table 1. JAMA Neurol. 2021;78(10):1278. doi:10.1001/jamaneurol.2021.2833
Monkeypox Resource Center